Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Trial will assess antibody response in people who did not respond to two-dose regimen.
Mobile clinics could be innovative strategy for expanding access to care and providing uninterrupted treatment for people who inject drugs.
Cancer, diabetes and Alzheimer’s would be the initial focus for the proposed agency within the National Institutes of Health.
People who have had COVID-19 appear to be protected against reinfection for at least a few months.
But American Indians and Alaska Natives saw the sharpest increase in deaths involving methamphetamines. Here’s a possible solution.
More than 95% of people who recovered from COVID-19 had durable immune system memory up to eight months after infection.
Anthony Fauci, President-elect Joe Biden and senior legislators were vaccinated publicly to demonstrate their confidence in vaccine safety.
The vaccine demonstrated 95% efficacy in an ongoing Phase III trial.
If passed, the law would boost liver disease research and create a national strategy to tackle non-alcoholic steatohepatitis.
The study asks whether certain approved therapies or late-stage investigational drugs show promise against COVID-19.
The trial is evaluating an investigational vaccine from Janssen that may require only one shot.
The trial will enroll healthy volunteers to test the vaccine’s safety and ability to trigger an immune response.
Americans are drinking more, which puts them at risk of alcohol-related liver disease, heart disease, cancer and accidents.
The American Cancer Society sets the record straight.
That’s the core message of an essay by Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases.
Nine grants will enable researchers to study CBD and other components of marijuana.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.